EXPERIMENTAL RESULTS OF COLORECTAL CANCER CHEMOPREVENTION BY CURCUMINOIDS LOADED NANO-CARRIER DRUG DELIVERY SYSTEM INCREASED IN VITRO BIOCOMPATIBILITY
Source abstract
Abstract
Colorectal cancer (CRC) has the second highest cancer mortality rate in Taiwan. Curcumin, a major ingredient in the popular spice - curry, is derived from the rhizome of curcuma longa. Curcumin derivatives, curcuminoids, have shown anti-cancer activity and apoptosis induction in a variety of cancer cells. We developed novel poloxamer 188 based oil-in-water (o/w) nanoemulsions (NE) containing curcuminoids for drug delivery systems (DDS) to enhance the localized delivery of curcuminoids to colorectal cancer. The size of curcuminoids loaded NEs (F1 to F4) was found to be less than 100 nm, and F2 and F3 could further increase the rectal bioavailability of curcuminoids via low mucosa permeation and high accumulation. The growth rate of 5 primary colon cancer cells was inhibited by F2 and F3. Our research demonstrates a curcuminoids loaded poloxamer 188-based nanoemulsion could be a potential formulation for the development of a colorectal DDS in colorectal cancer therapy.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Curcumin's Biomedical Applications · RNA Interference and Gene Delivery · Natural product bioactivities and synthesis
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References
Reference metadata was not supplied for this record.